BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48
Nasdaq News: Stocks
Here's Why I'm Buying Chainlink (LINK) Right Now
Nasdaq News: Markets
Alluvial Tactile Fund's Q2 2026 Investor Letter
Insider Monkey
Analysts Offer Insights on Consumer Cyclical Companies: Arcos Dorados Holdings (ARCO) and Nike (NKE)
TipRanks
Global annual AI server shipments, 2025-2026
DigiTimes: IT news from Asia
Analysts Conflicted on These Technology Names: Monday.com (MNDY), Nvidia (NVDA) and Synaptics (SYNA)
TipRanks
Should You Forget Tesla and Buy These 3 Robotics Stocks Instead?
Fool.com Headlines
Peter Lynch Averaged a 29.2% Annual Return Running Fidelity's Magellan Fund From 1977 to 1990. Here's What Made That Track Record Nearly Impossible to Repeat.
Nasdaq News: Markets
15 Press Releases You Need to See This Week
PR Newswire
Anthropic aims for mid-November IPO as it juggles relationship with Trump administration
DigiTimes: IT news from Asia
Citi Raised Its Bitcoin Target to $113,000 While Forecasting Just $5 Billion of Inflows. What Has to Go Right?
24/7 Wall St.
